Ledger.Open graph →
SEC Form D · Amendment · filed July 25, 2011

Selexagen Therapeutics, Inc

Offering
$597K
Sold
$597K
Exemption
—
Industry
Biotechnology
Location
SAN DIEGO, CA
Type
—

People & firms on this filing (8)

Scott L. Glenn · San Diego, CADirectorLauren G. Otsuki · San Diego, CAExec · DirectorRandall Woods · San Diego, CADirectorPatrick O'Connor · San Diego, CAExec · DirectorRobert J. Frohwein · Atlanta, GAExec · DirectorMarc J. Gorlin · Atlanta, GAExec · DirectorKathryn T. Petralia · Atlanta, GADirectorMark A. Ross · Redwood City, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗